Outsourced healthcare services provider, Ashfield, part of UDG Healthcare, has announced the launch of The Ashfield Solution, an agile, multi-channel engagement model underpinned by a field analytics engine.
The Ashfield Solution addresses the challenges of pharmaceutical companies needing to maintain or improve return on investment (ROI). Utilizing the AshfieldGuide, a sales analytics and planning platform, it provides a more efficient, impactful and agile sales model with the capability to flex resources in ‘real-time’ in reaction to market events.
The new model reportedly helps pharmaceutical companies optimize their investment in light of margin pressure, loss of exclusivity, new product data and new market entrants including biosimilars. It provides analytics capabilities in response to curve modeling, segmentation techniques, mix modeling and geospatial optimisation. In addition, the commercial model is said to deliver engagement optimization and monthly reporting on ROI, call attainment and performance.
For more information visit www.ashfieldhealthcare.com
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.